S. Møller

发表

Global microRNA Analysis of the NCI-60 Cancer Cell Panel

J. Gorodkin, R. Søkilde, B. Kaczkowski, 2011, Molecular Cancer Therapeutics.

Identification of Akt Pathway Inhibitors Using Redistribution Screening on the FLIPR and the IN Cell 3000 Analyzer

S. Møller, B. K. Lundholt, V. Linde, 2005, Journal of biomolecular screening.

Quantitative miRNA expression analysis: comparing microarrays with next-generation sequencing.

R. Søkilde, S. Møller, T. Litman, 2009, RNA.

Nuclear export inhibitors and kinase inhibitors identified using a MAPK-activated protein kinase 2 redistribution screen.

S. Møller, F. Loechel, Hans-Christian Pedersen, 2004, Assay and drug development technologies.

Efficient identification of miRNAs for classification of tumor origin.

T. Blondal, B. Nielsen, R. Søkilde, 2014, The Journal of molecular diagnostics : JMD.

Diagnostic and prognostic signatures from the small non-coding RNA transcriptome in prostate cancer

T. Visakorpi, S. Møller, T. Litman, 2012, Oncogene.

Real-world data on melanoma brain metastases and survival outcome

S. Møller, M. Donia, I. Svane, 2022, Melanoma research.

Identification and analysis of miRNAs in human breast cancer and teratoma samples using deep sequencing

Anders Krogh, Henrik Flyger, Niels Tolstrup, 2009, BMC Medical Genomics.

High levels of microRNA-21 in the stroma of colorectal cancers predict short disease-free survival in stage II colon cancer patients

H. Nielsen, N. Brünner, B. Nielsen, 2010, Clinical & Experimental Metastasis.

Robust one-day in situ hybridization protocol for detection of microRNAs in paraffin samples using LNA probes.

B. Nielsen, S. Møller, A. Baker, 2010, Methods.

The Rectal Cancer microRNAome – microRNA Expression in Rectal Cancer and Matched Normal Mucosa

Jochen Gaedcke, B. Michael Ghadimi, Thomas Ried, 2012, Clinical Cancer Research.

Identification and analysis of miRNAs in human breast cancer and teratoma samples using deep sequencing

A. Krogh, N. Tolstrup, S. Møller, 2009, BMC Medical Genomics.